Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.

Publication Type:

Journal Article


Multiple sclerosis (Houndmills, Basingstoke, England), Volume 17, Issue 2, p.204-13 (2011)


2011, Adolescent, Adult, Clinical Research Division, Disability Evaluation, Disease-Free Survival, Evidence-Based Medicine, Female, hematopoietic stem cell transplantation, Humans, Male, Middle Aged, Multiple Sclerosis, Chronic Progressive, Risk Assessment, Risk Factors, Time Factors, Transplantation Conditioning, Transplantation, Autologous, Treatment Outcome, Young Adult


The purpose of this systematic review was to evaluate the safety and efficacy of autologous hematopoietic cell transplantation in patients with progressive multiple sclerosis (MS) refractory to conventional medical treatment.